Carrières
Participants aux essais
Investisseurs
Envoyer un appel d'offre
Choix de la langue
Rechercher
Expertise scientifique
Expertise scientifique >
Domaines thérapeutiques
Domaines thérapeutiques >
Maladie auto-immune
Maladies cardiovasculaires
Dermatologie
Diabète et endocrinologie
Hépatologie
Maladies infectieuses et vaccins
Néphrologie
Neuroscience
Obesity Research at Fortrea
Oncologie
Ophtalmologie
Respiratory and Pulmonary
Santé de la femme
Domaines spécialisés
Domaines spécialisés >
Thérapies cellulaires et géniques
Pediatric Research at Fortrea
Maladies rares
Solutions internationales
Solutions internationales >
Développement clinique
Développement clinique >
Précoce : phase I / IIa
Phase tardive : IIb / III
RWE and Post-Approval Studies
Essais cliniques décentralisés
Gestion des données cliniques, analyses et rapports
Contrôle et gestion de projet pour les essais cliniques
Sécurité des patients et pharmacovigilance
Diversité et intégration dans les essais cliniques
Pharmacologie clinique
Pharmacologie clinique >
Unités de recherche clinique (URC)
Services d'expertise-conseil Fortrea
Services d'expertise-conseil Fortrea >
Expertise-conseil en stratégie réglementaire
Accès aux marchés et stratégie HEOR
Équipe de développement de produits
Technologies habilitantes
Technologies habilitantes >
Services cliniques mobiles
Modèles de services complet, fonctionnel et hybride
Modèles de services complet, fonctionnel et hybride >
Accès des patients
Accès des patients >
Pharmacie spécialisée
Développement de dispositifs médicaux et diagnostics
Développement de dispositifs médicaux et diagnostics >
Medical Device Development at Fortrea
Développement de diagnostic in vitro (DIV)
Fortrea Site Connections
Fortrea Site Connections >
Nos clients
Nos clients >
Pharmaceutique
Pharmaceutique >
Biotechnologie
Biotechnologie >
MedTech
MedTech >
Notre entreprise
Notre entreprise >
Blog
Blog >
Sites
Sites >
Investisseurs
Investisseurs >
Direction
Direction >
Actualités
Actualités >
Événements et webinaires
Événements et webinaires >
Qualité
Qualité >
Carrières
Choix de la langue
Nous contacter
Retour
Blog: Fresh insights driving agile collaboration
Accueil
/
Notre entreprise
/
Blog
11 juillet 2024
The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union
En savoir plus
about The journey of Advanced Therapy Medicinal Product (ATMP) studies in the European Union
3 juillet 2024
Clinical Development in the Precision Medicine Era
En savoir plus
about Clinical Development in the Precision Medicine Era
28 June 2024
Diversity Action Plans: What sponsors need to know about the latest FDA guidance
En savoir plus
about Diversity Action Plans: What sponsors need to know about the latest FDA guidance
24 June 2024
Enhancing endpoint protection in pain management clinical trials
En savoir plus
about Enhancing endpoint protection in pain management clinical trials
21 June 2024
Importance of patient perspectives in neurology clinical trials
En savoir plus
about Importance of patient perspectives in neurology clinical trials
11 June 2024
It's never too early for a thorough oncology product development strategy in the APAC region
En savoir plus
about It's never too early for a thorough oncology product development strategy in the APAC region
4 June 2024
Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey
En savoir plus
about Highlights from Asembia 2024 Summit: Key Takeaways for the Future of a Patients Journey
Le 31 mai 2024
Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars
En savoir plus
about Oncology in the news: Connect with Fortrea at ASCO and access our recent webinars
Le 31 mai 2024
Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation
En savoir plus
about Empowering young voices in pediatric clinical trials: Fortrea’s commitment to child rights and participation
Le 20 mai 2024
Celebrating Clinical Trials Day: A look back to move forward
En savoir plus
about Celebrating Clinical Trials Day: A look back to move forward
Le 15 mai 2024
Patient-Centric Solutions for Cell and Gene Therapy Trials
En savoir plus
about Patient-Centric Solutions for Cell and Gene Therapy Trials
Le 6 mai 2024
Scientific Research Amidst the Russia-Ukraine Conflict
Fortrea's efforts in continuing scientific research and clinical trials amidst the challenges posed by the Russia-Ukraine conflict.
En savoir plus
about Scientific Research Amidst the Russia-Ukraine Conflict
25 April 2024
Beauty and Personal Care Research | Sustainable Trends | Fortrea
Discover Fortrea's research on beauty and personal care, focusing on sustainable trends. Read our blog for insights into the future of beauty and personal care.
En savoir plus
about Beauty and Personal Care Research | Sustainable Trends | Fortrea
15 April 2024
Rare diseases: A spotlight on Gaucher disease research in India
Explore Fortrea's focus on Gaucher disease research in India, addressing rare diseases with innovative treatment approaches.
En savoir plus
about Rare diseases: A spotlight on Gaucher disease research in India
25 March 2024
Focusing on Rare Kidney Diseases with Unique Collaborative Efforts
Explore Fortrea's unique collaborative efforts in researching and addressing rare kidney diseases through advanced methodologies and patient-centric approaches.
En savoir plus
about Focusing on Rare Kidney Diseases with Unique Collaborative Efforts
14 March 2024
Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials
Learn about Fortrea's agile strategies for hybrid outsourcing in clinical trials, enhancing flexibility and efficiency.
En savoir plus
about Applying an Agile Approach to Hybrid Outsourcing in Clinical Trials
27 février 2024
Rare Disease Day: Celebrating Progress and Hope for the Future
Join Fortrea in celebrating Rare Disease Day, highlighting progress in medical research and hope for the future.
En savoir plus
about Rare Disease Day: Celebrating Progress and Hope for the Future
23 février 2024
Rare Disease Clinical Trials | Orphan Drug Research | Fortrea Blog
Explore Fortrea's advancements in rare disease clinical trials and orphan drug research. Read our blog for insights into our innovative research solutions.
En savoir plus
about Rare Disease Clinical Trials | Orphan Drug Research | Fortrea Blog
11 février 2024
Clinical Trials in Rare Disease | Fortrea
Discover Fortrea's efforts in conducting clinical trials for rare diseases, aiming to develop effective treatments.
En savoir plus
about Clinical Trials in Rare Disease | Fortrea
25 janvier 2024
Continuous Glucose Monitoring | Diabetes Management | Fortrea Blog
Explore key considerations for using continuous glucose monitoring in diabetes management. Read Fortrea's blog for insights into CGM technology and strategies.
En savoir plus
about Continuous Glucose Monitoring | Diabetes Management | Fortrea Blog
21 janvier 2024
Clinical Trials Regulation | Regulatory Updates | Fortrea Blog
Stay informed with Fortrea's blog on clinical trials regulation and regulatory updates. Prepare for upcoming changes and ensure compliance in clinical research.
En savoir plus
about Clinical Trials Regulation | Regulatory Updates | Fortrea Blog
8 janvier 2024
Innovative Advances in Ophthalmology Medical Device Development
Discover Fortrea's innovative advances in ophthalmology medical device development, enhancing eye disease treatments.
En savoir plus
about Innovative Advances in Ophthalmology Medical Device Development
12 December 2023
Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries
Fortrea addresses the challenges and strategies in conducting clinical trials for type 2 diabetes, aiming to improve treatment outcomes.
En savoir plus
about Addressing the competitive landscape for Type 2 Diabetes trials in APAC countries
4 December 2023
Fortrea Shanghai Office | Sustainability Initiatives | Fortrea Blog
Learn about Fortrea's Shanghai office and its sustainability initiatives. Explore our efforts towards promoting a greener and sustainable future.
En savoir plus
about Fortrea Shanghai Office | Sustainability Initiatives | Fortrea Blog
20 November 2023
SGLT2 Inhibitors for Pediatric Patients | Renal Protection | Fortrea Blog
Explore the benefits of SGLT2 inhibitors as renoprotective agents for pediatric patients. Fortrea's blog provides insights into diabetes medication and renal protection.
En savoir plus
about SGLT2 Inhibitors for Pediatric Patients | Renal Protection | Fortrea Blog
16 November 2023
Promoting Access to Innovative Cardiac Medical Devices
Fortrea's efforts in promoting access to innovative cardiac medical devices, aiming to improve cardiovascular health through cutting-edge technology.
En savoir plus
about Promoting Access to Innovative Cardiac Medical Devices
27 October 2023
Key takeaways from the 2023 SCDM AC & Leadership Forum
Discover the key insights and takeaways from the 2023 SCDM AC Leadership Forum, highlighting advancements and discussions in clinical data management.
En savoir plus
about Key takeaways from the 2023 SCDM AC & Leadership Forum
1 October 2023
Standardizing cosmetovigilence
Learn about Fortrea's efforts in standardizing cosmetovigilance to ensure the safety and efficacy of cosmetic products.
En savoir plus
about Standardizing cosmetovigilence
28 septembre 2023
Repousser les limites des thérapies cellulaires et géniques
Discover Fortrea's advancements in cell and gene therapy. Read our blog for insights into the latest breakthroughs and innovative treatments in genetic medicine.
En savoir plus
about Advancing cell and gene therapy frontiers
21 septembre 2023
Patient Safety in Clinical Trials | Fortrea Blog
Explore Fortrea's commitment to patient safety in clinical trials. Read our blog for insights and strategies to ensure patient protection and trial integrity.
En savoir plus
about Patient Safety in Clinical Trials | Fortrea Blog
21 septembre 2023
Leveraging Precision Medicine to Advance Clinical Trials in Latin America
Learn how Fortrea is advancing clinical trials in Latin America through precision medicine, enhancing treatment efficacy and patient outcomes.
En savoir plus
about Leveraging Precision Medicine to Advance Clinical Trials in Latin America
11 septembre 2023
Réparer, remplacer ou augmenter : Considérations clés pour les études reprises ou de transition dans les essais cliniques de dispositifs médicaux
Explore Fortrea's strategies for clinical trial rescue and transition, ensuring successful outcomes and continuity.
En savoir plus
about Fix, replace or augment: Key considerations for rescue or transition studies in medical device clinical trials